Daily Health Care News - 1/16/09
Posted on January 16th, 2009 by Jason Rosenbaum in News ClipsNEWS
Obama's Health Care Agenda Arrives In Washington - Forbes
President George W. Bush spent his first year focused on education, culminating with the passage of the No Child Left Behind bill. Barack Obama appears poised to do the same with health care.
The Public's Health Care Agenda for the New President and Congress - Kaiser Family Foundation
This survey captures the public's attitudes regarding the health care agenda for President-elect Obama and the new Congress in 2009. It assesses the relative priority placed on health care by the American public as part of addressing the economic recession and as a large scale reform issue. The public's priorities for health care reform and their views on a range of other health policy issues are presented.
Children's health insurance bill advances - Boston Globe
A key Senate committee voted yesterday to expand a children's health insurance program to cover an additional 4 million uninsured children. The vote came one day after the House overwhelmingly supported a similar measure.
Public wary of health reform trade-offs - Kansas City Star
Prospects for health reform drop significantly when Americans hear potential financial trade-offs associated with expanding health insurance coverage, a poll indicates.
PhRMA CEO Tauzin Expresses Opposition to Government Negotiating Medicare Drug Prices - Kaiser Family Foundation
Allowing Medicare to negotiate prescription drug prices on behalf of beneficiaries could reduce the number of drugs the program offers and result in higher costs for beneficiaries, Pharmaceutical Research and Manufacturers of America President and CEO Billy Tauzin said Wednesday, CQ HealthBeat reports. According to Tauzin, Medicare now offers access to thousands of drugs because the program relies on private-sector competition. Tauzin, speaking at a media roundtable, said, "When you put the government in the process you freeze out the private sector." He added that lower-than-expected monthly Medicare prescription drug benefit premiums and lower-than-estimated costs to the federal government show that Congress should not change the program.